|
|||||
|
|
Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24-week,randomized, double-blind,placebo-controlled,dose-ranging phase 2b trial |
|
| Authors: | Julie Dubourg MD Kohjiro Ueki MD Jean-Marie Grouin PhD Pascale Fouqueray MD |
| Affiliation: | 1. Poxel, Lyon, France;2. Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan;3. University of Rouen, Rouen, France |
| Abstract: | |
| Keywords: | imeglimin Japanese monotherapy type 2 diabetes |